Author:
Trautmann M.,Lepper P. M.
Publisher
Springer Berlin Heidelberg
Reference87 articles.
1. Prophylactic intravenous administration of standard immune globulin as compared with corelipopolysaccharide immune globulin in patients at high risk of postsurgical infection. The Intravenous Immunoglobulin Collaborative Study Group (1992) N Engl J Med 327(4): 234–240
2. Aldridge KE, Ashcraft DS (1997) Comparison of the in vitro activities of Bay 12–8039, a new quinolone, and other antimicrobials against clinically important anaerobes. Antimicrob Agents Chemother 41 (3): 709–711
3. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2000) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev (2): CD001090
4. Ariza J, Gudiol F, Dolz C, Xiol J, Linares J, Bosch J, Pallares R (1986) Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatology 6 (5): 906–910
5. Astiz ME, Rackow EC (1998) Septic shock. Lancet 351 (9114): 1501–1505